AlphAIalphai — Financial news for AI agents
prnewswire.comSEP 22 min read$CLMT

Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption Decision

Calumet, Inc. (CLMT) received full exemptions from the EPA for two small refinery petitions, reducing its RIN liability by 71 million RINs valued at $170 million. The remaining liability is 129 million RINs worth $309 million, pending further EPA discussions and legal reviews. Calumet operates in specialty products and renewable fuels.

Original reporting
prnewswire.com
Published Sep 2, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 1:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefRegulation
Primary signal
$CLMT
Bullish
high confidence
Mentioned
$CLMT
Relevance
8/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$CLMTBullishHigh
01

Why it matters

The exemption removes $170M of RIN liability, improving cash flow and reducing risk exposure.

02

Market read

Regulatory relief for Calumet could lift its stock and set a precedent for peers.

03

What to watch

Potential litigation from competitors challenging the exemptions.

Relevance 8/10Novelty 8/10Timing: today

Background

Calumet is a diversified specialty fuels and renewable fuel producer with twelve North American facilities.

Company-level read

Ticker impact

$CLMTBullishHigh confidence
Context

Calumet announced EPA granted full exemptions on two small refinery petitions, cutting $170M of RIN liability.

Expected impact

Potential upside of several percent as investors re‑rate the company.

Evidence & confidence

The $170M liability reduction is material for a mid‑cap specialty fuels producer and is disclosed for the first time.

Market effects

Sector

Other small‑refinery operators may see similar EPA exemption requests, affecting the renewable fuels sector.

Regional

U.S. renewable fuel market could see tighter RIN pricing pressure.

Global

Limited to U.S. regulated fuel producers.

Counterpoint

What could challenge this read

If EPA later revokes exemptions, liability could rebound, pressuring the stock.

Key entities

  • company
    Calumet, Inc.

    Issuer of the press release and subject of the EPA exemption.

  • regulator
    U.S. Environmental Protection Agency

    Granted the small refinery exemptions.

Read at source← All news

Related articles

AUG 27
$CLMTMed

S&P upgrades Calumet rating to B- on stronger earnings

S&P Global Ratings upgraded Calumet Inc. to 'B-' from 'CCC+' due to stronger earnings in H1 2026 and improved credit metrics. The company's earnings grew on high margins for specialty oils and renewable fuels. S&P expects adjusted debt to EBITDA of 6x-7x in the next 12 months. Calumet redeemed $100M in senior unsecured notes in July 2026 and plans to expand sustainable aviation fuel production.

investing.com2 min
AUG 14
$CLMTMedAI 8/10

Calumet (CLMT) Q2 2026 Earnings Call Transcript

Calumet (CLMT) reported Q2 2026 Adjusted EBITDA with Tax Attributes of $175.2 million, driven by Specialty Products and Solutions at $161.7 million. Net loss was $95.9 million, mainly from non-cash RINs expenses of $163.6 million. The company said it repaid $115 million of debt in July, including $100 million note redemption, and discussed SAF expansion and hedges.

fool.com10 min
AUG 10
$CLMTMed

Why Calumet Stock Is Rocketing Higher Today

Calumet (CLMT) shares rose 15.2% to about $5.99 by 2:36 p.m. ET after a 6.8% drop the prior week. Bank of America kept a buy rating and raised its price target to $45 from $38, citing stronger free cash flow and debt retirement. Calumet reported about $54M free cash flow in Q2 2026 and retired $115M debt in July.

fool.com3 min
AUG 10
$CLMTMedAI 8/10

CLMT Stock Jumps As Revenue Beats And Debt Falls

Calumet Inc (NASDAQ: CLMT) shares rose about 10.56% after Q2 results and guidance. The company reported Q2 revenue of $1.45B versus a FactSet estimate of $1.12B, with EPS improving to -$1.09 from -$1.70. Operating cash flow was about $92.3M and free cash flow about $54M, alongside $115M debt reduction in July. Goldman Sachs raised its CLMT price target to $40 from $36 but kept a Neutral rating.

timothysykes.com6 min
AUG 10
$CLMTMed

CLMT Stock Jumps As Revenue Beat Fuels Deleveraging Story

Calumet Inc. (CLMT) shares rose about 10.56% after the company reported Q2 revenue of $1.45B versus $1.12B expected, and narrowed its EPS loss to -$1.09 from -$1.70. The quarter included $54M free cash flow and management cited $115M debt reduction in July, alongside a MaxSAF 150 expansion at Montana Renewables.

stockstotrade.com6 min
AUG 7
$CLMTMed

Why Calumet Stock Flopped on Friday

Calumet (CLMT) shares fell about 6% on Friday after its Q2 earnings showed a surprise net loss. Revenue rose to just under $1.45B, up about 41% YoY, but adjusted net loss was $95.9M, or $1.09/share, versus a year-ago deficit of $147.9M. Analysts expected profit of $0.17/share. Long-term debt exceeded $2.2B.

fool.com4 min
Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption Decision — alphai